Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG Immunisation at Birth and Childhood Morbidity
NCT01694108Phase 4Completed
- Start
- Sep 2012
- Primary completion
- Jan 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of bcg vaccine in Tuberculosis (TB), infectious disease, Eczema, asthma, food allergy. Started Sep 2012; status: completed.
02
Drugs
bcg vaccine
03
Conditions
Tuberculosis (TB)infectious diseaseEczemaasthmafood allergy
Beyond the preview
Go deeper on NCT01694108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01694108.